Acadia Healthcare Company, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the three and nine months ended September 30, 2026, for the period reported under NASDAQ:ACHC.

Key Highlights

  • Quarterly revenue: Acadia reported revenue of $895,309 thousand for the three months ended September 30, 2026, compared with $851,573 thousand in the same period of 2025, according to the filing.
  • Net income attributable to Acadia: The company reported $34,486 thousand for Q3 2026, versus $36,246 thousand in Q3 2025, as stated in the condensed consolidated statements of income.
  • Nine-month diluted EPS: Diluted earnings per share attributable to Acadia stockholders for the nine months ended September 30, 2026 was $0.54, compared with $0.82 for the same period in 2025, per the filing.
  • Shares outstanding at November 3, 2026: The cover page states there were 92,966,685 shares of common stock outstanding as of that date.
  • Total assets: Total assets were $5,554,590 thousand at September 30, 2026, versus $5,527,448 thousand at December 31, 2025, according to the balance sheet.
  • Long-term debt: Long-term debt stood at $2,319,859 thousand at September 30, 2026, down from $2,471,529 thousand at December 31, 2025, per the filing.

Acadia Healthcare's Third-Quarter 2026 Financial Results and Balance Sheet Position

Acadia Healthcare Company, Inc., a provider of behavioral health services headquartered in Franklin, Tennessee, operates inpatient psychiatric facilities and other behavioral health programs. According to the Form 10-Q filed November 4, 2026, revenue for the three months ended September 30, 2026 reached $895,309 thousand, an increase from $851,573 thousand in the corresponding prior-year quarter. Total expenses for the same quarter were $838,841 thousand, resulting in income before income taxes of $56,468 thousand, the filing disclosed.

For the nine months ended September 30, 2026, the company reported revenue of $2,589,950 thousand, compared with $2,491,310 thousand for the nine months ended September 30, 2025. Net income attributable to Acadia Healthcare for the nine-month period was $49,519 thousand, versus $74,747 thousand in the prior-year period, according to the filing. The provision for income taxes for the nine-month period was $34,065 thousand, compared with $18,139 thousand a year earlier.

The condensed consolidated balance sheet as of September 30, 2026 showed total equity of $2,022,492 thousand, up from $1,948,960 thousand at December 31, 2025. The accumulated deficit narrowed to $716,322 thousand from $765,841 thousand over the same interval, per the filing. Transaction, legal and other costs were $23,739 thousand for Q3 2026, a reduction from $42,919 thousand in Q3 2025. The filing also noted a legal settlements gain of $7,151 thousand in the third quarter of 2026, and a loss on impairment of $3,546 thousand for the same period.

What Was Disclosed

Acadia Healthcare's 10-Q for the quarter ended September 30, 2026 disclosed revenue, earnings, balance sheet data, and share count information. The filing covered financial results for both the three-month and nine-month periods, as well as changes in equity and debt levels from December 31, 2025.